A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause Article Proceedings Paper

sustainable development goals

authors

publication date

  • February 1, 2009

webpage

published in

keywords

  • desvenlafaxine succinate
  • hot flushes
  • menopause
  • nonhormonal treatment
  • vasomotor symptoms

volume

  • 200

issue

  • 2